News
OpenAI Acquires Orchestra Bio
OpenAI bought Orchestra Bio, a platform that helps biopharma teams manage drug development, integrating its team and technology with OpenAI's Rosalind life‑sciences initiative to build AI agents for research and regulatory workflows.